LOI with with BiogalenysVancouver, British Columbia – July 2, 2013 –
Sirona Biochem Corp. (TSX-V: SBM,
OTCQX: SRBCF, Frankfurt: ZSB) is pleased to announce the signing of a Letter of Intent (LOI) for a collaboration with Biogalenys. The goal of the collaboration is to study Sirona Biochem’s patented glycoprotein (cell preservation) technology and to develop preclinical data supporting multiple targeted applications.
Using its proprietary chemistry technique, Sirona Biochem has developed and patented a cell preservation technology that (early tests have shown) protects human fibroblast cells from damage in stressed environments. Potential applications of this technology include, but are not limited to: anti-aging cream, sunscreen / UV protection, wound care, reduced scarring, frostbite protection, stem cell preservation, beta islet cell preservation, platelet and red blood cell preservation, and increased preservation times for tissue explants and organ transplantation.
The proposed 3 year collaboration will focus on first studying the application of Sirona Biochem’s cell preservation technology for use as a cosmetic anti-aging active ingredient and as a preservative adjuvant for tissue explants.
“We are excited to be creating a second project partnership with Biogalenys,” said Neil Belenkie, CEO of Sirona Biochem.
“We look forward to continuing the success that our companies achieved on our skin lightening project; applying our shared expertise in the study and development of our new cell preservation technology”.
“We are extremely happy to continue our collaboration with Sirona Biochem and to work in partnership on their scientific innovations in the future, which will allow the simultaneous development of our two companies on an international level,” said Pascal Svinareff, CEO of Biogalenys .
About Biogalenys
Biogalenys is a French laboratory (CRO) specialized in studies of transmembrane passage across several models of epithelia. Biogalenys provides, tests according to GLP or not, for active ingredients and chemical compounds and biological assays to serve the pharmaceutical and cosmetic industries. The laboratory designs the studies, conduct assays, completes data interpretation and classifies the absorption potential of drug and compounds, using different models for in-vitro, in-vivo and ex-vivo assays. Biogalenys is involved in several projects (approved by Cosmetic Valley) in research in cosmetic using efficient test with culture cells models.
For more information please visit:
https://www.biogalenys.com